Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis
Introduction: Hyperphosphatemia is an independent risk factor for mortality in chronic kidney disease (CKD) patients. Objectives: This systematic review and meta-analysis aimed to investigate the effect of Sevelamer on serum phosphorus levels in CKD and hemodialysis patients. Materials and Methods:...
Saved in:
Main Authors: | Farshad Gharebakhshi (Author), Mohammad Hossein Taklif (Author), Arash Izadpanah Ghahremani (Author), Mohamad Khaledi (Author), Sara Abbasian (Author), Seyedeh Mahsa Shariati Sough (Author), Fatemeh Vashahi Torfi (Author), Hamidreza Khodabandeh (Author), Elnaz Hajian (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
by: Vincenzo Savica, et al.
Published: (2008) -
Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action
by: Bahaa Eldin Zayed, et al.
Published: (2015) -
Prime determinants of serum phosphorus level in hemodialysis patients
Published: (2014) -
Emerging Effects of Sevelamer in Chronic Kidney Disease
by: Ryota Ikee, et al.
Published: (2013) -
Binding interactions with sevelamer and polystyrene sulfonate in vitro
by: Inge R.F. vanBerlo‐van de Laar, et al.
Published: (2021)